Correction: Tumor suppressor RARRES1 links tubulin deglutamylation to mitochondrial metabolism and cell survival

Oncotarget. 2021 Oct 26;12(22):2305-2306. doi: 10.18632/oncotarget.28093.

Authors

Sara Maimouni^{1

2}, Mi-Hye Lee^{3

2}, You-Me Sung^{3

2}, Michael Hall³, Arpita Roy⁴, Chokri Ouaari^{3

4}, Yoo-Seok Hwang⁵, Justin Spivak³, Eric Glasgow³, Matthew Swift³, Jay Patel³, Amrita Cheema³, Deepak Kumar⁴, Stephen Byers^{3

1}

Affiliations

¹ Department of Biochemical, Molecular and Cellular Biology, Georgetown University, Washington, DC, USA.
² These authors have contributed equally to this article.
³ Department of Oncology, Georgetown-Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
⁴ University of the District of Columbia, Washington, DC, USA.
⁵ Cancer & Developmental Biology Laboratory, National Cancer Institute-Frederick, Frederick, MD, USA.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.26600.].

Copyright: © 2021 Maimouni et al.

Publication types

Published Erratum